Cite
HARVARD Citation
Taha, A. et al. (n.d.). P15: Hematological adverse events as predictors of response to pegylated interferon and ribavirin treatment in patients with chronic hepatitis C genotype 4. Journal of viral hepatitis. p. 24. [Online].